CSPC Innovation Pharmaceutical Co., Ltd. (SHE:300765)
China
· Delayed Price · Currency is CNY 29.68
+2.93 (10.95%)
Feb 21, 2025, 3:04 PM CST
SHE:300765 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 20, 2025 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 41,332 | 42,873 | 9,767 | 8,376 | 7,858 | 7,140 | Upgrade
|
| Market Cap Growth | 89.02% | 338.97% | 16.61% | 6.58% | 10.06% | - | Upgrade
|
| Enterprise Value | 40,974 | 39,717 | 7,864 | 6,725 | 6,463 | 5,759 | Upgrade
|
| Last Close Price | 29.68 | 30.26 | 7.20 | 6.92 | 6.46 | 5.85 | Upgrade
|
| PE Ratio | 80.54 | 56.74 | 13.45 | 21.30 | 26.21 | 26.13 | Upgrade
|
| PS Ratio | 20.22 | 17.14 | 3.72 | 4.53 | 5.96 | 5.68 | Upgrade
|
| PB Ratio | 10.84 | 8.43 | 2.48 | 2.54 | 2.92 | 2.96 | Upgrade
|
| P/TBV Ratio | 12.03 | 8.52 | 2.51 | 2.59 | 3.00 | 3.04 | Upgrade
|
| P/FCF Ratio | - | 51.56 | 18.54 | 86.64 | 33.97 | 34.12 | Upgrade
|
| P/OCF Ratio | - | 46.24 | 15.24 | 28.68 | 22.51 | 22.64 | Upgrade
|
| EV/Sales Ratio | 20.05 | 15.88 | 2.99 | 3.64 | 4.91 | 4.58 | Upgrade
|
| EV/EBITDA Ratio | 62.94 | 45.47 | 9.60 | 13.34 | 16.26 | 17.30 | Upgrade
|
| EV/EBIT Ratio | 77.21 | 51.30 | 10.53 | 15.46 | 18.78 | 20.16 | Upgrade
|
| EV/FCF Ratio | -480.32 | 47.76 | 14.93 | 69.57 | 27.94 | 27.52 | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.01 | 0.00 | - | - | Upgrade
|
| Debt / EBITDA Ratio | 0.00 | 0.00 | 0.02 | 0.00 | - | - | Upgrade
|
| Debt / FCF Ratio | - | 0.00 | 0.04 | 0.01 | - | - | Upgrade
|
| Asset Turnover | 0.37 | 0.49 | 0.63 | 0.55 | 0.45 | 0.59 | Upgrade
|
| Inventory Turnover | 4.18 | 5.93 | 5.97 | 5.59 | 4.97 | 4.84 | Upgrade
|
| Quick Ratio | 2.14 | 7.77 | 5.00 | 5.31 | 7.54 | 4.46 | Upgrade
|
| Current Ratio | 2.69 | 8.26 | 5.47 | 6.09 | 8.17 | 4.83 | Upgrade
|
| Return on Equity (ROE) | 10.78% | 16.73% | 20.07% | 13.12% | 11.75% | 16.02% | Upgrade
|
| Return on Assets (ROA) | 6.03% | 9.47% | 11.22% | 8.12% | 7.41% | 8.42% | Upgrade
|
| Return on Capital (ROIC) | 6.92% | 10.69% | 12.86% | 9.08% | 8.43% | 10.25% | Upgrade
|
| Return on Capital Employed (ROCE) | 11.05% | 15.12% | 18.67% | 13.05% | 12.65% | 11.65% | Upgrade
|
| Earnings Yield | 1.24% | 1.76% | 7.44% | 4.69% | 3.82% | 3.83% | Upgrade
|
| FCF Yield | -0.21% | 1.94% | 5.39% | 1.15% | 2.94% | 2.93% | Upgrade
|
| Dividend Yield | 0.90% | 0.88% | 0.96% | 1.00% | 0.55% | 0.41% | Upgrade
|
| Payout Ratio | 72.89% | 12.95% | 11.30% | 10.68% | 9.34% | - | Upgrade
|
| Buyback Yield / Dilution | 7.05% | -3.82% | 0.02% | -13.53% | -6.56% | -24.77% | Upgrade
|
| Total Shareholder Return | 7.95% | -2.94% | 0.98% | -12.53% | -6.01% | -24.36% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.